BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 30197263)

  • 1. Evaluation of Radiation Therapy Treatment Plans in a Randomized Phase 2 Trial Comparing 2 Schedules of Twice-Daily Thoracic Radiation Therapy in Limited Stage Small Cell Lung Cancer.
    Levin N; Killingberg KT; Halvorsen TO; Danielsen S; Grønberg BH
    Int J Radiat Oncol Biol Phys; 2024 Apr; ():. PubMed ID: 38583494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary analysis of a phase II randomized trial Radiation Therapy Oncology Group (RTOG) 0212: impact of different total doses and schedules of prophylactic cranial irradiation on chronic neurotoxicity and quality of life for patients with limited-disease small-cell lung cancer.
    Wolfson AH; Bae K; Komaki R; Meyers C; Movsas B; Le Pechoux C; Werner-Wasik M; Videtic GM; Garces YI; Choy H
    Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):77-84. PubMed ID: 20800380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Consolidative thoracic radiation therapy for extensive-stage small cell lung cancer in the era of first-line chemoimmunotherapy: preclinical data and a retrospective study in Southern Italy.
    Longo V; Della Corte CM; Russo A; Spinnato F; Ambrosio F; Ronga R; Marchese A; Del Giudice T; Sergi C; Casaluce F; Gilli M; Montrone M; Gristina V; Sforza V; Reale ML; Di Liello R; Servetto A; Lipari H; Longhitano C; Vizzini L; Manzo A; Cristofano A; Paolelli L; Nardone A; De Summa S; Perrone A; Bisceglia C; Derosa C; Nardone V; Viscardi G; Galetta D; Vitiello F
    Front Immunol; 2023; 14():1289434. PubMed ID: 38304255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current Treatments for Surgically Resectable, Limited-Stage, and Extensive-Stage Small Cell Lung Cancer.
    Stinchcombe TE
    Oncologist; 2017 Dec; 22(12):1510-1517. PubMed ID: 28778960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Prophylactic Cranial Irradiation and Consolidative Thoracic Radiation Therapy for Extensive Stage Small-Cell Lung Cancer in the Transition to the Chemo-Immunotherapy Era: A Single Institution Series.
    Gross AJ; Sheikh S; Kharouta M; Chaung K; Choi S; Margevicius S; Fu P; Machtay M; Bruno DS; Dowlati A; Biswas T
    Clin Lung Cancer; 2023 Dec; 24(8):696-705. PubMed ID: 37993218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-Dose Once-Daily Thoracic Radiotherapy in Limited-Stage Small-Cell Lung Cancer: CALGB 30610 (Alliance)/RTOG 0538.
    Bogart J; Wang X; Masters G; Gao J; Komaki R; Gaspar LE; Heymach J; Bonner J; Kuzma C; Waqar S; Petty W; Stinchcombe TE; Bradley JD; Vokes E
    J Clin Oncol; 2023 May; 41(13):2394-2402. PubMed ID: 36623230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of Toxic Effects Associated With Dose-Fractionated Radiotherapy Among Patients With Cancer and Comorbid Collagen Vascular Disease.
    Yoon SM; Chu FI; Ruan D; Steinberg ML; Raldow A; Lee P
    JAMA Netw Open; 2021 Feb; 4(2):e2034074. PubMed ID: 33599771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intrathoracic Progression Is Still the Most Dominant Failure Pattern after First-Line Chemo-immunotherapy in Extensive-Stage Small-Cell Lung Cancer: Implications for Thoracic Radiotherapy.
    Kim D; Kim HJ; Wu HG; Lee JH; Kim S; Kim TM; Kim JS; Kim BH
    Cancer Res Treat; 2024 Apr; 56(2):430-441. PubMed ID: 37933113
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrospective analysis of optimal timing of thoracic radiotherapy for driver gene-negative metastatic non-small cell lung cancer.
    Wang Y; Gao Z; Zhao W; Li H; Meng X; Li J
    Thorac Cancer; 2024 Mar; 15(8):642-653. PubMed ID: 38323356
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors associated with acute esophagitis during radiation therapy for lung cancer.
    Herr DJ; Yin H; Bergsma D; Dragovic AF; Matuszak M; Grubb M; Dominello M; Movsas B; Kestin LL; Boike T; Bhatt A; Hayman JA; Jolly S; Schipper M; Paximadis P;
    Radiother Oncol; 2024 May; 197():110349. PubMed ID: 38815695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pneumonitis in Patients Receiving Thoracic Radiotherapy and Osimertinib: A Multi-Institutional Study.
    Banla LI; Tzeng A; Baillieul JP; Kandekhar MJ; Fitzgerald KJ; LoPiccolo J; Poitras HA; Soto DE; Rotow JK; Singer L; Willers H; Kozono DE; Janne PA; Mak RH; Piotrowska Z; Keane FK; Kann BH
    JTO Clin Res Rep; 2023 Oct; 4(10):100559. PubMed ID: 37732171
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Term Outcomes After Concurrent Once- or Twice-Daily Chemoradiation in Limited-Stage Small Cell Lung Cancer: A Brief Report From the CONVERT Trial.
    Walls GM; Mistry H; Barlesi F; Bezjak A; Pechoux CL; O'Brien M; Van Meerbeeck JP; Blackhall F; Faivre-Finn C
    Int J Radiat Oncol Biol Phys; 2024 Mar; ():. PubMed ID: 38521132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiation-induced Adaptive Response: New Potential for Cancer Treatment.
    Coleman CN; Eke I; Makinde AY; Chopra S; Demaria S; Formenti SC; Martello S; Bylicky M; Mitchell JB; Aryankalayil MJ
    Clin Cancer Res; 2020 Nov; 26(22):5781-5790. PubMed ID: 32554542
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Dose/Fractionation Debate in Limited-Stage Small Cell Lung Cancer.
    Du K; Liao X; Kishi K
    Cancers (Basel); 2024 May; 16(10):. PubMed ID: 38791986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting interleukin-17 in radiation-induced toxicity and cancer progression.
    Baindara P
    Cytokine Growth Factor Rev; 2024 Feb; 75():31-39. PubMed ID: 38242827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and Treatment Outcome of Radiation Pneumonitis in Patients With Limited-stage Small Cell Lung Cancer Treated With Concurrent Accelerated Hyperfractionated Radiation Therapy and Chemotherapy.
    Doshita K; Tabuchi Y; Kenmotsu H; Omori S; Kawabata T; Kodama H; Nishioka N; Miyawaki E; Iida Y; Mamesaya N; Kobayashi H; Ko R; Wakuda K; Ono A; Naito T; Murakami H; Mori K; Harada H; Kaneko T; Takahashi T
    Adv Radiat Oncol; 2023; 8(2):101129. PubMed ID: 36845617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiation and Systemic Therapy for Limited-Stage Small-Cell Lung Cancer.
    Bogart JA; Waqar SN; Mix MD
    J Clin Oncol; 2022 Feb; 40(6):661-670. PubMed ID: 34985935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Epigallocatechin-3-Gallate as a Radioprotective Agent During Radiotherapy of Lung Cancer Patients: A 5-Year Survival Analysis of a Phase 2 Study.
    Zhu W; Zhao Y; Zhang S; Li X; Xing L; Zhao H; Yu J
    Front Oncol; 2021; 11():686950. PubMed ID: 34178681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Twice-daily Thoracic Radiotherapy for Limited-stage Small-cell Lung Cancer Does Not Increase the Incidence of Acute Severe Esophagitis.
    Suzuki R; Wei X; Allen PK; Welsh JW; Cox JD; Komaki R; Lin SH
    Clin Lung Cancer; 2018 Nov; 19(6):e885-e891. PubMed ID: 30197263
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.